David J. Armstrong - 31 Mar 2023 Form 4 Insider Report for Cano Health, Inc.

Role
General Counsel, Chief Compliance Officer and Secretary
Signature
/s/ David J. Armstrong
Issuer symbol
N/A
Transactions as of
31 Mar 2023
Net transactions value
$0
Form type
4
Filing time
04 Apr 2023, 20:42:51 UTC
Previous filing
09 Jan 2023
Next filing
02 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CANO Class A Common Stock Award +70,108 +15% 550,263 31 Mar 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CANO Stock Option (Right to Buy) Award $0 +146,757 $0.000000 146,757 31 Mar 2023 Class A Common Stock 146,757 $0.9100 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares represent restricted stock units ("RSUs") granted under the Cano Health, Inc. 2021 Stock Option and Incentive Plan. Each unit represents a right to receive one share of the Issuer's Class A Common Stock. The RSUs vest as to 50% of the RSUs on December 31st, 2023 and the remaining 50% of the RSUs vest on December 31st, 2024. The RSUs were granted on March 31, 2023.
F2 The stock option is granted under the Cano Health, Inc. 2021 Stock Option and Incentive Plan and is scheduled to vest over four years, with 25% of the shares underlying the award vesting on March 31, 2024, and 25% of the shares underlying the award vesting at the end of each successive one-year period thereafter. The stock option was granted on March 31, 2023.

Remarks:

General Counsel, Chief Compliance Officer and Secretary